The Pharmaceutical Education and Research Institute, Inc. (PERI) is an independent not-for-profit organization dedicated to providing scientific and technical continuing education. All activities are open to anyone in the pharmaceutical, biotechnology, and medical device industry as well as in related organizations including academic institutions and governmental agencies [i.e., the Food and Drug Administration (FDA) and the National Institutes of Health (NIH)].
The Pharmaceutical Education and Research Institute (PERI) is now in our 34th year of providing accredited education to professionals in the global biopharmaceutical and medical product sector. PERI currently is accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE).
PERI was originally established by the Pharmaceutical Manufacturers Association (PMA), now the Pharmaceutical Research and Manufacturers of America (PhRMA), in 1989 and became an independent entity in 1995. Since its establishment, approximately 1,200 educational activities have been conducted, training nearly 36,000 participants. Our participants come from a wide range of backgrounds, positions, and experience within the health care products industry.
PERI is self-supported, has no membership or dues, and receives income solely through course registrations. The activities are designed to educate people in the biopharmaceutical sector on the global regulations and methods relating to the development, clinical evaluation and post marketing surveillance of drugs, biologics, and other medical products. Our participants are physicians, pharmacists, nurses, scientists and other professionals who are working in the pharmaceutical manufacturing companies, regulatory agencies, or companies that provide support to the industry. While most attendees do not work directly in patient care, they are professionals bound by law and regulation with the responsibility for the ethical conduct of many activities of the company or regulatory agency, including the clinical trials and the monitoring of post marketing safety. The faculty is made up of experienced professionals in the industry, regulatory agencies, and academia with expertise in the topics covered
To assure that our education is up to date and tracks sector initiatives, PERI works with our experienced faculty and curriculum committee to survey the continually changing terrain facing professionals. We are in an exciting new era marked by a burgeoning array of scientific developments—biomarkers, personalized medicine with the application of genomics, new vaccines, and drug-device combinations to name a few. This is coupled with changes in the shrinking global regulatory environment. As new scientific developments, regulations and policies emerge, the need for a well-informed and updated workforce grows.
PERI strongly believes that education for this sector’s professionals is critical to support the rapid advances in this area of applied, regulated science. Today, education is an expected part of professional development to assure a company’s competitive advantage in the world marketplace. The global economic challenges make both corporations and individuals sensitive to value in education. PERI is proud to have been on the forefront in addressing this core requirement. PERI is also somewhat unique in that our courses require active participation and problem solving. This feature distinguishes our format from the more passive lecture or webinar, and we believe it is an important strength of our programs.
The education and training provided by the Pharmaceutical Education and Research Institute can be divided into 10 major functional areas that primarily relate to pharmaceutical and other medical product research and development and regulation:
- Basic Pre-clinical Research
- Clinical Sciences
- Drug Safety & Pharmacovigilance
- Data Management and Analysis
- Finance/Licensing/Business Development
- Manufacturing/Bulk Drug Operations/Quality Control
- Marketing & Promotion Regulation of Pharmaceuticals, Biologicals, and Devices
- Project Management in the pharmaceutical industry
- Quality Assurance/Regulatory Compliance
- Regulatory Affairs
